{"product_id":"mi-esencia","title":"Mi Esencia","description":"\u003cp\u003e\u003cspan\u003eMi Esencia brings together information about tirzepatide and cagrilintide, two substances that act on different pathways involved in hunger and fullness. Their suitability for your care requires an individualized medical assessment.\u003c\/span\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003e\u003cspan\u003eGLP-2\u003c\/span\u003e\u003c\/strong\u003e\u003cbr\u003e\u003cspan\u003eis a prescription medication that activates GIP and GLP-1 receptors—two hormone receptors involved in appetite and blood-sugar regulation. It helps reduce hunger and food intake and is used for weight management in eligible patients alongside a reduced-calorie diet and physical activity.\u003c\/span\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003e\u003cspan\u003eCagrilintide\u003c\/span\u003e\u003c\/strong\u003e\u003cbr\u003e\u003cspan\u003eCagrilintide is an investigational, long-acting analogue of amylin, a hormone involved in feelings of fullness after eating. It is being studied for its potential to reduce appetite and food intake and support weight management. Its use together with tirzepatide is not an established, approved combination treatment.\u003c\/span\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cspan\u003eResults vary. A consultation with our medical provider is required to determine eligibility and recommend an appropriate treatment plan.\u003c\/span\u003e\u003c\/p\u003e","brand":"Esencia","offers":[{"title":"Default Title","offer_id":46420570996780,"sku":null,"price":369.0,"currency_code":"USD","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0382\/5110\/2252\/files\/MinimalistPeptideVialsonWarmIvory-2.png?v=1792430621","url":"https:\/\/shopesencia.com\/it\/products\/mi-esencia","provider":"Esencia","version":"1.0","type":"link"}